Natural bioactive compounds that trigger apoptosis in medicinal plants might be a promising new source of anti-cancer medications. This study aimed to estimate the anti-cancer potential of the powerful medicinal plant Chrysanthemum indicum. The whole plant extract was extracted in n-hexane and ethanol solvents to test anticancer and antioxidative capabilities on the cancer HepG2 cell line. The cells in the untreated group had not been exposed to any of the plant extracts. Ethanol and n-hexane extracts were administered to the treated cell lines. Cell viability was estimated by employing standard methodologies for the anticancer potential. Cell death and viability were measured by MTT, crystal violet, and trypan blue tests. The rate of apoptosis was measured in the groups using an Annexin-V ELISA. Furthermore, antioxidant enzyme activity studies were carried out to investigate the scavenging activities of nitric oxide, DPHH radicals, H2O2, and superoxide, scavenging power of the extracts. Cell lines, HepG2 administered with plant extracts showed lower viability, decreased proliferation with increased apoptosis compared to untreated control cells, according to the findings. Plant extract-treated cancer cells have stronger anti-oxidative scavenging activity than untreated cancer cells. In comparison to the n-hexane extract, the ethanol extract exhibited stronger anti-cancer and antioxidative capability against cancer cells. It was concluded that Chrysanthemum indicum ethanol and n-hexane extracts induce anticancer activity in cancer cell lines by increasing apoptosis, antioxidant status, and decrease proliferation.